Microfluidic-controlled manufacture of liposomes for the solubilisation of a poorly water soluble drug

Int J Pharm. 2015 May 15;485(1-2):122-30. doi: 10.1016/j.ijpharm.2015.02.063. Epub 2015 Feb 25.

Abstract

Besides their well-described use as delivery systems for water-soluble drugs, liposomes have the ability to act as a solubilizing agent for drugs with low aqueous solubility. However, a key limitation in exploiting liposome technology is the availability of scalable, low-cost production methods for the preparation of liposomes. Here we describe a new method, using microfluidics, to prepare liposomal solubilising systems which can incorporate low solubility drugs (in this case propofol). The setup, based on a chaotic advection micromixer, showed high drug loading (41 mol%) of propofol as well as the ability to manufacture vesicles with at prescribed sizes (between 50 and 450 nm) in a high-throughput setting. Our results demonstrate the ability of merging liposome manufacturing and drug encapsulation in a single process step, leading to an overall reduced process time. These studies emphasise the flexibility and ease of applying lab-on-a-chip microfluidics for the solubilisation of poorly water-soluble drugs.

Keywords: Bilayer loading; High throughput; Liposomes; Microfluidics; Poorly soluble drugs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chemistry, Pharmaceutical
  • Cholesterol / chemistry*
  • Kinetics
  • Lab-On-A-Chip Devices
  • Microfluidic Analytical Techniques* / instrumentation
  • Nanoparticles
  • Particle Size
  • Phosphatidylcholines / chemistry*
  • Propofol / chemistry*
  • Solubility
  • Solvents / chemistry
  • Technology, Pharmaceutical / instrumentation
  • Technology, Pharmaceutical / methods*
  • Unilamellar Liposomes

Substances

  • Phosphatidylcholines
  • Solvents
  • Unilamellar Liposomes
  • Cholesterol
  • Propofol